Ramtin Agah - Sep 30, 2021 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin Agah
Stock symbol
RNXT
Transactions as of
Sep 30, 2021
Transactions value $
$0
Form type
4
Date filed
10/4/2021, 08:11 PM
Previous filing
Jun 17, 2022
Next filing
Mar 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Employee Stock Option (right to buy) Award $0 +52.2K $0.00 52.2K Sep 30, 2021 Common Stock 52.2K $6.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest in 48 equal monthly installments beginning on September 26, 2021.